169 related articles for article (PubMed ID: 7695248)
1. Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.
Entenza JM; Blatter M; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1994 Dec; 38(12):2683-8. PubMed ID: 7695248
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2004 Jan; 48(1):86-92. PubMed ID: 14693523
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci.
Entenza JM; Caldelari I; Glauser MP; Moreillon P
J Antimicrob Chemother; 1999 Dec; 44(6):775-86. PubMed ID: 10590278
[TBL] [Abstract][Full Text] [Related]
4. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.
Blatter M; Fluckiger U; Entenza J; Glauser MP; Francioli P
Antimicrob Agents Chemother; 1993 Sep; 37(9):1971-6. PubMed ID: 8239615
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.
Cremieux AC; Saleh-Mghir A; Vallois JM; Maziere B; Muffat-Joly M; Devine C; Bouvet A; Pocidalo JJ; Carbon C
Antimicrob Agents Chemother; 1992 Oct; 36(10):2216-21. PubMed ID: 1332590
[TBL] [Abstract][Full Text] [Related]
6. Sparfloxacin therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Maserati R; Cagni AE; Segú C
Chemotherapy; 1996; 42(2):133-9. PubMed ID: 8697888
[TBL] [Abstract][Full Text] [Related]
7. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
Azoulay-Dupuis E; Vallee E; Veber B; Bedos JP; Bauchet J; Pocidalo JJ
Antimicrob Agents Chemother; 1992 Dec; 36(12):2698-703. PubMed ID: 1336343
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.
Entenza JM; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1999 Jan; 43(1):77-84. PubMed ID: 9869569
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae.
López Fornas F; Martínez García F; Pérez Salmeron J; Roldán Conesa D; Cortés Sanchez R; García Alberola A; Ruíz Gómez J; Gómez Gómez J; Valdés Chávarri M
J Antimicrob Chemother; 2001 May; 47(5):623-9. PubMed ID: 11328774
[TBL] [Abstract][Full Text] [Related]
10. Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.
Pankuch GA; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1994 Sep; 38(9):2065-72. PubMed ID: 7811020
[TBL] [Abstract][Full Text] [Related]
11. Successful ceftriaxone therapy of endocarditis due to penicillin non-susceptible viridans streptococci.
Shelburne SA; Greenberg SB; Aslam S; Tweardy DJ
J Infect; 2007 Feb; 54(2):e99-101. PubMed ID: 16824611
[TBL] [Abstract][Full Text] [Related]
12. Effect of gentamicin dosing interval on efficacy of penicillin or ceftriaxone treatment of experimental endocarditis due to penicillin-susceptible, ceftriaxone-tolerant viridans group streptococci.
Brandt CM; Warner CB; Rouse MS; Steckelberg JM; Wilson WR
Antimicrob Agents Chemother; 1996 Dec; 40(12):2901-3. PubMed ID: 9124865
[TBL] [Abstract][Full Text] [Related]
13. Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.
Piper KE; Rouse MS; Ronningen KL; Steckelberg JM; Wilson WR; Patel R
Antimicrob Agents Chemother; 2000 Sep; 44(9):2554-6. PubMed ID: 10952616
[TBL] [Abstract][Full Text] [Related]
14. Y-688, a new quinolone active against quinolone-resistant Staphylococcus aureus: lack of in vivo efficacy in experimental endocarditis.
Entenza JM; Marchetti O; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 1998 Aug; 42(8):1889-94. PubMed ID: 9687379
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
Chambers HF; Xiang Q; Liu ; Chow LL; Hackbarth C
Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of sparfloxacin activity and spectrum against 24,940 pathogens isolated in the United States and Canada, the final analysis.
Jones RN; Ballow CH; Schentag JJ; Johnson DM; Deinhart JA
Diagn Microbiol Infect Dis; 1998 May; 31(1):313-25. PubMed ID: 9597392
[TBL] [Abstract][Full Text] [Related]
17. Antipneumococcal activities of gemifloxacin compared to those of nine other agents.
Davies TA; Kelly LM; Pankuch GA; Credito KL; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2000 Feb; 44(2):304-10. PubMed ID: 10639354
[TBL] [Abstract][Full Text] [Related]
18. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic management of outpatients with endocarditis due to penicillin-susceptible streptococci.
Stamboulian D; Bonvehi P; Arevalo C; Bologna R; Cassetti I; Scilingo V; Efron E
Rev Infect Dis; 1991; 13 Suppl 2():S160-3. PubMed ID: 2017645
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.
Ostergaard C; Sørensen TK; Knudsen JD; Frimodt-Møller N
Antimicrob Agents Chemother; 1998 Jul; 42(7):1706-12. PubMed ID: 9661008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]